136 related articles for article (PubMed ID: 3189339)
21. Maple syrup urine disease: the E1beta gene of human branched-chain alpha-ketoacid dehydrogenase complex has 11 rather than 10 exons, and the 3' UTR in one of the two E1beta mRNAs arises from intronic sequences.
Chuang JL; Cox RP; Chuang DT
Am J Hum Genet; 1996 Jun; 58(6):1373-7. PubMed ID: 8651316
[No Abstract] [Full Text] [Related]
22. [Maple syrup urine disease].
Matsuda I
Tanpakushitsu Kakusan Koso; 1988 Apr; 33(5):585-8. PubMed ID: 3270867
[No Abstract] [Full Text] [Related]
23. Complementation analysis in lymphoid cells from five patients with different forms of maple syrup urine disease.
Jinno Y; Akaboshi I; Matsuda I
Hum Genet; 1984; 68(1):54-6. PubMed ID: 6500555
[TBL] [Abstract][Full Text] [Related]
24. Maple syrup urine disease caused by a partial deletion in the inner E2 core domain of the branched chain alpha-keto acid dehydrogenase complex due to aberrant splicing. A single base deletion at a 5'-splice donor site of an intron of the E2 gene disrupts the consensus sequence in this region.
Mitsubuchi H; Nobukuni Y; Akaboshi I; Indo Y; Endo F; Matsuda I
J Clin Invest; 1991 Apr; 87(4):1207-11. PubMed ID: 2010537
[TBL] [Abstract][Full Text] [Related]
25. Diagnosis and mutational analysis of maple syrup urine disease using cell cultures.
Chuang JL; Chuang DT
Methods Enzymol; 2000; 324():413-23. PubMed ID: 10989449
[No Abstract] [Full Text] [Related]
26. Molecular genetic characterization of maple syrup urine disease in European families.
Peinemann F; Wendel U; Danner DJ
Biochem Med Metab Biol; 1993 Dec; 50(3):338-45. PubMed ID: 8123297
[TBL] [Abstract][Full Text] [Related]
27. Maple syrup urine disease. Complete defect of the E1 beta subunit of the branched chain alpha-ketoacid dehydrogenase complex due to a deletion of an 11-bp repeat sequence which encodes a mitochondrial targeting leader peptide in a family with the disease.
Nobukuni Y; Mitsubuchi H; Akaboshi I; Indo Y; Endo F; Yoshioka A; Matsuda I
J Clin Invest; 1991 May; 87(5):1862-6. PubMed ID: 2022752
[TBL] [Abstract][Full Text] [Related]
28. Identification of a cDNA clone in lambda gt11 for the transacylase component of branched chain ketoacid dehydrogenase.
Litwer S; Danner DJ
Biochem Biophys Res Commun; 1985 Sep; 131(2):961-7. PubMed ID: 2932110
[TBL] [Abstract][Full Text] [Related]
29. Gene analysis of Mennonite maple syrup urine disease kindred using primer-specified restriction map modification.
Mitsubuchi H; Matsuda I; Nobukuni Y; Heidenreich R; Indo Y; Endo F; Mallee J; Segal S
J Inherit Metab Dis; 1992; 15(2):181-7. PubMed ID: 1356170
[TBL] [Abstract][Full Text] [Related]
30. Maple syrup urine disease: clinical and biochemical significance of gene analysis.
Nobukuni Y; Mitsubuchi H; Akaboshi I; Indo Y; Endo F; Matsuda I
J Inherit Metab Dis; 1991; 14(5):787-92. PubMed ID: 1664011
[No Abstract] [Full Text] [Related]
31. Molecular basis of intermittent maple syrup urine disease: novel mutations in the E2 gene of the branched-chain alpha-keto acid dehydrogenase complex.
Tsuruta M; Mitsubuchi H; Mardy S; Miura Y; Hayashida Y; Kinugasa A; Ishitsu T; Matsuda I; Indo Y
J Hum Genet; 1998; 43(2):91-100. PubMed ID: 9621512
[TBL] [Abstract][Full Text] [Related]
32. Gene preference in maple syrup urine disease.
Nellis MM; Danner DJ
Am J Hum Genet; 2001 Jan; 68(1):232-7. PubMed ID: 11112664
[TBL] [Abstract][Full Text] [Related]
33. A T-to-A substitution in the E1 alpha subunit gene of the branched-chain alpha-ketoacid dehydrogenase complex in two cell lines derived from Menonite maple syrup urine disease patients.
Matsuda I; Nobukuni Y; Mitsubuchi H; Indo Y; Endo F; Asaka J; Harada A
Biochem Biophys Res Commun; 1990 Oct; 172(2):646-51. PubMed ID: 2241958
[TBL] [Abstract][Full Text] [Related]
34. Conservation of primary structure in the lipoyl-bearing and dihydrolipoyl dehydrogenase binding domains of mammalian branched-chain alpha-keto acid dehydrogenase complex: molecular cloning of human and bovine transacylase (E2) cDNAs.
Lau KS; Griffin TA; Hu CW; Chuang DT
Biochemistry; 1988 Mar; 27(6):1972-81. PubMed ID: 2837277
[TBL] [Abstract][Full Text] [Related]
35. Regional assignment of two genes of the human branched-chain alpha-keto acid dehydrogenase complex: the E1 beta gene (BCKDHB) to chromosome 6p21-22 and the E2 gene (DBT) to chromosome 1p31.
Zneimer SM; Lau KS; Eddy RL; Shows TB; Chuang JL; Chuang DT; Cox RP
Genomics; 1991 Jul; 10(3):740-7. PubMed ID: 1889817
[TBL] [Abstract][Full Text] [Related]
36. Heterogeneity of mutations in maple syrup urine disease (MSUD): screening and identification of affected E1 alpha and E1 beta subunits of the branched-chain alpha-keto-acid dehydrogenase multienzyme complex.
Nobukuni Y; Mitsubuchi H; Hayashida Y; Ohta K; Indo Y; Ichiba Y; Endo F; Matsuda I
Biochim Biophys Acta; 1993 Nov; 1225(1):64-70. PubMed ID: 8161368
[TBL] [Abstract][Full Text] [Related]
37. Targeting E3 component of alpha-keto acid dehydrogenase complexes.
Johnson MT; Yang HS; Patel MS
Methods Enzymol; 2000; 324():465-76. PubMed ID: 10989453
[No Abstract] [Full Text] [Related]
38. Maple syrup urine disease in Mennonites. Evidence that the Y393N mutation in E1 alpha impedes assembly of the E1 component of branched-chain alpha-keto acid dehydrogenase complex.
Fisher CR; Chuang JL; Cox RP; Fisher CW; Star RA; Chuang DT
J Clin Invest; 1991 Sep; 88(3):1034-7. PubMed ID: 1885764
[TBL] [Abstract][Full Text] [Related]
39. Occurrence of a Tyr393----Asn (Y393N) mutation in the E1 alpha gene of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease patients from a Mennonite population.
Fisher CR; Fisher CW; Chuang DT; Cox RP
Am J Hum Genet; 1991 Aug; 49(2):429-34. PubMed ID: 1867199
[TBL] [Abstract][Full Text] [Related]
40. Genetic defects in E3 component of alpha-keto acid dehydrogenase complexes.
Patel MS; Hong YS; Kerr DS
Methods Enzymol; 2000; 324():453-64. PubMed ID: 10989452
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
